Fundraising FoxTheory Ventures — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Aampe provides AI agents that personalize customer messaging at the individual-user level, running thousands of parallel experiments to optimize engagement content, timing, and variants.
AI & Machine LearningMarketing TechSaaS
Schaun Wheeler(Founder)inKate Field(Founder)inPaul Meinshausen(Founder)Sami Abboud(Founder)
Co-investorsPeak XV PartnersSurgeZ47Blume VenturesCrane Venture PartnersMatrix
Dropzone AI builds AI agents that investigate security alerts, hunt threats, and respond to cyberattacks for security teams and organizations.
AI & Machine LearningCybersecurityEnterprise Software
Edward Wu(Founder)in
Co-investorsDecibel PartnersIn-Q-TelMadrona Venture GroupPioneer Square LabsPioneer Square VenturesRedpoint Ventures
Exin Therapeutics develops an AI-guided drug discovery platform that uses experimental mouse studies to identify neurological therapies, starting with epilepsies linked to autism and Parkinson's disease.
BiotechHealthtechSan Francisco, US
Gabriel Ocana Santero(CEO)inMarko Tvrdic(COO)inIvan Alex Priela Lazarte(Executive Officer, Director)inIvan Lazarte(Founder)
Co-investorsAlumni VenturesY Combinator468 CapitalFounder CapitalOurCrowdTekedia Capital
Tobiko builds a data transformation platform with state-aware architecture designed to reduce warehouse costs and build times for data engineering teams.
Data & InfrastructureDeveloper ToolsSaaS
Iaroslav ZeigermaninTyson MaoinToby Maoin
Co-investors20SALESUnusual Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.